Ionis Pharmaceuticals Drops Another After Phase 3 Setback
Ionis Pharmaceuticals dropped again after a Phase 3 failure in transthyretin amyloid cardiomyopathy, triggering a bro...
Explore practical signs you should modify your spending plan and a straightforward approach to refreshing priorities for better outcomes.
22,050 articlesIonis Pharmaceuticals dropped again after a Phase 3 failure in transthyretin amyloid cardiomyopathy, triggering a bro...
A new wave in space tech is redefining how satellites connect the world. This guide explains why rocket shakes satell...
California's new EV incentive is tilting the playing field for Rivian and Tesla. With Q1 results out, investors are w...
Investors confront a Musk-power dilemma: bet on SpaceX's growth trajectory or Tesla's robotics push. This analysis br...
As stocks edge higher in mid-2026, a 64-year dividend king stands out as a pristine entry point for income-focused in...
United Airlines unveils an empty-middle-seat row in Economy Plus on its latest jets, a move aimed at boosting comfort...
Pi Network's Core Team rolled out a major redesign of the mining app and Pioneer profile page, promising clearer navi...
Qualcomm's AI data-center push is fueling a fresh round of upside bets, with investors watching for a sustained ramp ...
Mark Cuban is reviving the debate over wage inequality by urging companies to grant stock to every worker. His pitch ...
A disciplined approach using SPYI could deliver about $100 in monthly cash from a $10,000 investment, driven by optio...
NVIDIA’s new alliance with Meta Platforms tightens the AI infrastructure backbone, pushing AMD to the back foot as in...
Colin Kaepernick unveils Lumi, an AI-literacy platform aimed at youth, delivering a personal-finance angle on activis...